Product References — Innovative Grade US Origin Rat Wistar Complement Serum

Innovative Grade US Origin Rat Sprague Dawley Complement Serum from Innovative Research was used in the following study:   A Complement-Mediated Rat Xenotransfusion Model of Platelet Refractoriness Adrianne I. Enos, Pamela S. Hair, Neel K. Krishna, Kenji M. Cunnion Molecular Immunology May 30, 2020 Platelet refractoriness, or the failure of transfused platelets to increase a patient’s platelet count that results in continued thrombocytopenia, is a concerning medical issue that has an urgent need for a solution. This continued state of thrombocytopenia can increase the risk of spontaneous bleeding in the patient and can result in increased medical expenses due to...

Innovative Research's Innovative Grade US Origin Wistar Rat Complement Serum was recently used in the following study: Inhibitor (s) of the classical complement pathway in mouse serum limit the utility of mice as experimental models of neuromyelitis opticaJ Ratelade, AS Verkman - Molecular Immunology, 2014We conclude that mice have limited utility as models of NMO. 2. Materials and methods. 2.1. Reagents and antibodies. Complement/sera from mouse (CD1 and C57BL/6 strains), rat (Wistar strain), guinea pig and human were purchased from Innovative Research (Novi, MI).

Innovative Research's Innovative Grade US Origin Wistar Rat Complement Serum was recently used in the following study: Complement inhibition significantly decreases red blood cell lysis in a rat model of acute intravascular hemolysisTA Shah, CT Mauriello, PS Hair, JA Sharp, PS Kumar - Transfusion, 2014Complement-sufficient Wistar rat serum (WRS) and complement-deficient WRS were purchased from Innovative Research (Novi, MI).